In mouse models, OPN overexpression significantly increased atherosclerotic lesions [43], while depletion of one or both OPN genes attenuated angiotensin II–accelerated atherosclerosis [44] and treatment with liraglutide significantly attenuated OPN expression in a rat model of metabolic syndrome [45]. This evidence concerns the gene SPP1 and metabolic syndrome.